medigraphic.com
ISSN 0210-5187 (Electronic)

2018, Number 3

<< Back Next >>

Med Cutan Iber Lat Am 2018; 46 (3)

Clinical and histopathological characteristics of pyoderma gangrenosum in two hospitals in Medellin, Colombia. Case series

Cuéllar MC, Peña ZEB, Mejía AM, Londoño Á

Language: Spanish
References: 20
Page: 180-185
PDF size: 336.33 Kb.


ABSTRACT

Pyoderma gangrenosum is a neutrophilic dermatosis; its diagnosis can be a challenge in clinical practice. We describe the clinical and histological characteristics of seven cases of gangrenous disease diagnosed in two hospitals in Medellin, Colombia. The clinical characteristics agree with those described in the literature, and in the biopsy, the extension of the neutrophilic infiltrate for the diagnosis may be useful.


REFERENCES

  1. Hadi A, Lebwohl M. Clinical features of pyoderma gangrenosum and current diagnostic trends. J Am Acad Dermatol. 2010; 64: 950-954.

  2. Bhat RM, Nandakishore B, Sequeira FF, Sukumar D, Kamath GH, Martis J et al. Pyoderma gangrenosum: an Indian perspective. Clin Exp Dermatol. 2010; 36: 242-247.

  3. Jaimes-López N, Molina V, Arroyave JE, Vásquez LA, Ruiz AC, Castaño R et al. Development of pyoderma gangrenosum during therapy with infliximab. J Dermatol Case Rep. 2009; 3 (2): 20-23.

  4. Cañas CA, Durán CE, Bravo JC, Castaño DE, Tobón GJ. Leg ulcers in the antiphospholipid syndrome may be considered as a form of pyoderma gangrenosum and they respond favorably to treatment with immunosuppression and anticoagulation. Rheumatol Int. 2010; 30 (9): 1253-1257.

  5. Cadavid M, Palacios CP, Molina AL, Gómez LM, Restrepo R. Pioderma gangrenoso: reporte de caso. MEDICINA U.P.B. 2012; 31 (1): 59-62.

  6. Severiche DF, Velandia O, Saldarriaga EL. Pioderma gangrenoso como síndrome paraneoplásico de un tumor tipo Phyllodes Borderline. Acta Med Colomb. 2014; 39: 207-210.

  7. Moreno LH, Arrunátegui A. Pioderma gangrenoso tratado con rifampicina. Colombia Médica [Internet]. 2008 [Consultado: 15 de abril de 2017]; 39 (2). Disponible en: http://colombiamedica.univalle.edu.co/index.php/comedica/article/view/574/921

  8. Segura Charry JS, Jaimes DA, Londoño JD. Pioderma gangrenoso refractario: utilidad de la terapia combinada. Enfoque en beneficio de la terapia hiperbárica en su tratamiento. Rev Colomb Reumatol. 2013; 20: 171-176.

  9. Ahronowitz I, Harp J, Shinkai K. Etiology and management of pyoderma gangrenosum. A comprehensive review. Am J Clin Dermatol. 2012; 13: 191-211.

  10. Braswell SF, Kostopoulos TC, Ortega-Loayza AG. Pathophysiology of pyoderma gangrenosum: an updated review. J Am Acad Dermatol. 2015; 73: 691-698.

  11. Binus AM, Qureshi AA, Li VW, Winterfield LS. Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patients. Br J Dermatol. 2011; 165: 1244-1250.

  12. Saracino A, Kelly R, Liew D, Chong A. Pyoderma gangrenosum requiring inpatient management: a report of 26 cases with follow up. Australas J Dermatol. 2011; 52: 218-221.

  13. Pereira N, Brites MM, Gonçalo M, Tellechea O, Figueiredo A. Pyoderma gangrenosum—a review of 24 cases observed over 10 years. Int J Dermatol. 2013; 52 (8): 938-945.

  14. López de Maturana LD, Amaro BP, Aranibar DL, Segovia GL. Pioderma gangrenoso: experiencia clínica en 11 pacientes. Rev Méd Chile [Internet]. 2001 [citado 20 de junio de 2016]; 129 (9): 1044-1050. Disponible en: http://dx.doi.org/10.4067/S0034-98872001000900010.

  15. Mlika RB, Riahi I, Fenniche S, Mokni M, Dhaoui MR, Dess N et al. Pyoderma gangrenosum: a report of 21 cases. Int J Dermatol. 2002; 41: 65-68.

  16. Ye MJ, Ye JM. Pyoderma gangrenosum: a review of clinical features and outcomes of 23 cases requiring inpatient management. Dermatol Res Pract. 2014; 2014: 461467.

  17. Von den Driesch P. Pyoderma gangrenosum: a report of 44 cases with follow-up. Br J Dermatol. 1997; 137 (6): 1000-1005.

  18. Powell FC, Schroeter AL, Su WP, Perry HO. Pyoderma gangrenosum: a review of 86 patients. Q J Med. 1985; 55 (217): 173-186.

  19. Sanders S, Tahan SR, Kwan T, Magro CM. Giant cells in pyoderma gangrenosum. J Cutan Pathol. 2001; 28 (2): 97-100.

  20. Baranska-Rybak W, Kakol M, Naesstrom M, Komorowska O, Sokolowska-Wojdylo M, Roszkiewicz J. A retrospective study of 12 cases of pyoderma gangrenosum: why we should avoid surgical intervention and what therapy to apply. Am Surg. 2011; 12: 1644-1649.




2020     |     www.medigraphic.com